Neuropathic Pain Following Surgery for Malignant Peripheral Nerve Sheath Tumors

被引:1
作者
Raasveld, Floris V. [1 ,2 ,3 ]
Hanna, Tareq [2 ]
Pacheco, Fernando J. [2 ]
Gonzalez, Marcos R. [4 ]
Johnston, Benjamin [5 ]
Lozano-Calderon, Santiago A. [4 ]
Valerio, Ian L. [1 ]
Eberlin, Kyle R. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Dept Gen Surg, Div Plast & Reconstruct Surg, Boston, MA 02114 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Hand & Arm Ctr, Dept Orthoped Surg, Boston, MA USA
[3] Erasmus Univ, Erasmus Med Ctr, Dept Plast Reconstruct & Hand Surg, Rotterdam, Netherlands
[4] Harvard Med Sch, Massachusetts Gen Hosp, Dept Orthoped Surg, Boston, MA USA
[5] Harvard Med Sch, Dept Neurosurg, Brigham & Womens Hosp, Boston, MA USA
关键词
Malignant peripheral nerve sheath tumor; Neuropathic pain; Survival; En bloc excision; Targeted muscle reinnervation; SURVIVAL;
D O I
10.1245/s10434-025-17001-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMalignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue sarcomas that pose significant challenges in surgical management. This study aims to examine the anatomic distribution of MPNSTs, analyze survival rates and predictive factors for survival, and investigate the prevalence of neuropathic pain in patients who have undergone MPNST resection.Patients and MethodsA retrospective analysis of 119 patients who underwent MPNST resection was conducted. Additionally, a cross-sectional survey was administered and completed by 39 surviving patients to assess neuropathic pain prevalence using the NRS (0-10 scale) and the s-DN4 questionnaire, and quality of life (QoL) using the EQ-5D-5L index (0-1 scale).ResultsMPNSTs most commonly occurred in the lower extremity (42.9%), followed by the upper extremity (21.0%), trunk (19.3%), head and neck (11.8%), and pelvis (5.0%). Female sex (OR: 0.25, 95% CI: 0.10-0.61) and absence of metastases (OR: 0.15, 95% CI: 0.05-0.52) were significantly associated with lower odds of mortality. Among survey respondents, 82.1% reported neuropathic pain following MPNST resection. The patients reported a mean EQ-5D-5L index score of 0.566 (+/- 0.253) as compared with an EQ-5D-5L of 0.851 (+/- 0.205) for the US general population.ConclusionsThe high prevalence of neuropathic pain following MPNST resection and its significant impact on QoL highlights the need for improved pain management strategies. Nerve-sparing and/or nerve-reconstructive techniques during or after tumor resection should be considered. Future research should focus on identifying risk factors for neuropathic pain development and evaluating the efficacy of preventive measures to improve long-term pain outcomes for surviving patients with MPNST.
引用
收藏
页码:3741 / 3751
页数:11
相关论文
共 37 条
  • [1] International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis - PubMed, (2024)
  • [2] Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases - PubMed, (2024)
  • [3] Dunn G.P., Spiliopoulos K., Plotkin S.R., Et al., Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1, J Neurosurg, 118, 1, pp. 142-148, (2013)
  • [4] Nagabushan S., Lau L.M.S., Barahona P., Et al., Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor, NPJ Precis Oncol, 5, 1, (2021)
  • [5] Anghileri M., Miceli R., Fiore M., Et al., Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution, Cancer, 107, 5, pp. 1065-1074, (2006)
  • [6] Aslami Z.V., Leland C.R., Strike S.A., Et al., Symptomatic neuroma development following en bloc resection of skeletal and soft tissue tumors: a retrospective analysis of 331 cases, Plast Reconstr Surg
  • [7] Park J.W., Kim H.S., Yun J.Y., Han I., Neuropathic pain after sarcoma surgery: prevalence and predisposing factors, Medicine, 97, 21, (2018)
  • [8] Cuschieri S., The STROBE guidelines. Saudi J Anaesth, 13, (2019)
  • [9] Bouhassira D., Attal N., Alchaar H., Et al., Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4), Pain, 114, 1-2, pp. 29-36, (2005)
  • [10] Jensen M.P., Chodroff M.J., Dworkin R.H., The impact of neuropathic pain on health-related quality of life: review and implications, Neurology, 68, 15, pp. 1178-1182, (2007)